Repare Therapeutics Inc. (RPTX)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -93.80M -29.05M -106.91M -53.42M -27.22M -14.28M -7.80M
Depreciation & Amortization 1.95M 1.98M 1.47M 897.00K 605.00K 407.00K 102.00K
Stock-Based Compensation 25.06M 19.69M 12.83M 2.54M 511.00K 306.00K 34.00K
Other Working Capital -57.12M 10.90M 4.64M 42.40M 5.75M -494.00K -491.00K
Other Non-Cash Items -5.19M -3.94M 1.87M 890.00K 1.71M 1.13M 1.43M
Deferred Income Tax - 3.62M 149.00K 588.00K -629.00K 306.00K -11.00K
Change in Working Capital -55.18M 8.03M 4.79M 42.42M 6.59M -484.00K 239.00K
Operating Cash Flow -127.16M 322.00K -85.80M -6.08M -18.43M -12.62M -6.01M
Capital Expenditures -1.94M -602.00K -1.69M -2.24M -1.30M -583.00K -1.16M
Acquisitions - 175.18M 40.00K - - - -
Purchase of Investments -179.02M -256.58M -7.48M -7.53M - - -
Sales Maturities Of Investments 259.00M 81.40M 7.45M - - - -
Other Investing Acitivies - -175.18M 14.00K -7.53M - - -
Investing Cash Flow 78.04M -175.78M -1.68M -9.76M -1.30M -583.00K -1.16M
Debt Repayment - - - - - - 1.50M
Common Stock Repurchased 689.00K 433.00K - - - - -
Dividend Paid - - - - - - -
Other Financial Acitivies 842.00K 880.00K 1.27M 15.80M 103.24M - 28.96M
Financial Cash Flow 842.00K 880.00K 95.56M 247.84M 103.24M - 30.46M
Net Cash Flow -48.25M -174.91M 8.03M 231.39M 84.08M -13.46M 23.30M
Free Cash Flow -129.10M -280.00K -87.49M -8.32M -19.73M -13.20M -7.16M